Alexion Pharmaceuticals Inc. (ALXN) Nasdaq Global Select
117.052.432.12%
CloseJanuary 18, 2019

News: updated – 21-Jan 06:06


Will Positive Phase III Data For Roche’s Anti IL-6 Antibody Spell Trouble For Alexion’s C5 Inhibitor In NMOSD?11-Jan 10:24(SeekingAlpha)

NMOSD Background Neuromyelitis optica spectrum disorder ((NMOSD)) is a rare autoimmune disorder that is very similar to multiple sclerosis. There are several ways patients can develop the disorder; however, the most common (about 3/4th of patients) cause is the production of auto-antibodies …